Diligence memo · auto-generated · as of July 2, 2026
Medicus Pharma Ltd.
Medicus Pharma Ltd. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Medicus Pharma Ltd. operates in Pharma, based in TORONTO.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Medicus Pharma Ltd. has raised $16M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $11M on 2024-05-03.
Most recent recorded round closed around 2024-05-03.
Valuation (modeled)modeled
Provath models Medicus Pharma Ltd. at approximately $61M (range $13M–$137M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.89× the median modeled value of Series A Pharma companies in 2022–2024 (24 peers) — value vs value, same stage and era. Within the normal band (89% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 4 months.
Last raise 2.2 yr ago; this sector typically re-raises about every 16 months.
Slightly overdue versus sector cadence.
The last round stepped up 2.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 75% of Pharma peers (310 compared).
Modeled value ranks above 58% of those peers.
Closest niche peers: Carmine Therapeutics, Inc., Triomics, Inc., Spiral Therapeutics Inc, Convelo Therapeutics, Inc., ADvantage Therapeutics, Inc..
Peoplefiled
11 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.